Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.
I recently bought some EAPH, but should have bought more of ATTBF.
Man, there are too many players being attracted to this growing sector.
I also picked up one of the more safer plays.
MJNA[playing the conservative side].
Honestly, If EAPH goes up very much next week, I will sell them and buy some more of ATTBF.
They are the most structurally formatted company in the whole group.
They have all the bases Covered and they are very violatile.
I wish You and everyone else in this Marijuana Sector the best of luck in your pursuit of a secure Financial Future.
Believe me it will happen.
Just a matter of time.
The people of the world are speaking out as I write this Post.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.